Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle.
The objective of this study was to develop an optimal vaccination strategy for Bovine viral diarrhea virus (BVDV). The E2 protein of BVDV plays a major protective role against BVDV infection. In order to be able to compare DNA, protein and DNA prime-protein boost regimens, a plasmid was constructed encoding a secreted form of the NADL strain E2 protein (pMASIA-tPAsDeltaE2). Furthermore, a pure secreted recombinant DeltaE2 (rDeltaE2) protein was produced. The rDeltaE2 protein was formulated with a combination of Emulsigen and CpG oligodeoxynucleotide. Groups of calves were immunized with pMASIA-tPAsDeltaE2 or with rDeltaE2, or first with pMASIA-tPAsDeltaE2 and then with rDeltaE2. To evaluate the protection against BVDV, calves were challenged with BVDV strain NY-1 after the last immunization. Although all immunized calves developed humoral and cellular immune responses, the antibody responses in the DNA prime-protein boost group were stronger than those elicited by either the DNA vaccine or the protein vaccine. In particular, E2-specific antibody titres were enhanced significantly after boosting the DeltaE2 DNA-primed calves with rDeltaE2 protein. Moreover, protection against BVDV challenge was obtained in the calves treated with the DNA prime-protein boost vaccination regimen, as shown by a significant reduction in weight loss, viral excretion and lymphopenia, compared with the unvaccinated calves and the animals immunized with the DNA or protein only. These results demonstrate the advantage of a DNA prime-protein boost vaccination approach in an outbred species.
Liang
Rong
R
Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, SK S7N 5E3, Canada.
van den Hurk
Jan V
JV
Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, SK S7N 5E3, Canada.
Babiuk
Lorne A
LA
Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, SK S7N 5E3, Canada.
van Drunen Littel-van den Hurk
Sylvia
S
Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, SK S7N 5E3, Canada.
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001835:Body Weight; D001912:Bovine Virus Diarrhea-Mucosal Disease / Q000517:prevention & control; D019556:COS Cells; D002417:Cattle; D002460:Cell Line; D002522:Chlorocebus aethiops; D018899:CpG Islands / Q000276:immunology*; D004279:DNA, Viral / Q000276:immunology*; D001908:Diarrhea Viruses, Bovine Viral / Q000276:immunology*; D007074:Immunoglobulin G / Q000097:blood; D007962:Leukocytes / Q000821:virology; D009666:Nose / Q000821:virology; D014759:Viral Envelope Proteins / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology
D000914:Antibodies, Viral; D004279:DNA, Viral; D007074:Immunoglobulin G; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C076551:gp53, bovine viral diarrhea virus